Purdue Puts Forth FDA Decisions As Defense To Massachusetts Opioid Suit

Purdue says Commonwealth is trying to hold it liable for conduct FDA has authorized; citing agency's approval of long-term use of OxyContin for chronic pain, company asks court to dismiss complaint.